Literature DB >> 18382737

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

Myron S Cohen1, Nick Hellmann, Jay A Levy, Kevin DeCock, Joep Lange.   

Abstract

The most up-to-date estimates demonstrate very heterogeneous spread of HIV-1, and more than 30 million people are now living with HIV-1 infection, most of them in sub-Saharan Africa. The efficiency of transmission of HIV-1 depends primarily on the concentration of the virus in the infectious host. Although treatment with antiviral agents has proven a very effective way to improve the health and survival of infected individuals, as we discuss here, the epidemic will continue to grow unless greatly improved prevention strategies can be developed and implemented. No prophylactic vaccine is on the horizon. However, several behavioral and structural strategies have made a difference--male circumcision provides substantial protection from sexually transmitted diseases, including HIV-1, and the application of antiretroviral agents for prevention holds great promise.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382737      PMCID: PMC2276790          DOI: 10.1172/JCI34706

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  132 in total

1.  HIV-1 nomenclature proposal.

Authors:  D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

Review 2.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

3.  Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.

Authors:  Bisola Ojikutu
Journal:  J Infect Dis       Date:  2007-12-01       Impact factor: 5.226

4.  Interaction of non-antibody factors with HIV in plasma.

Authors:  G T Spear
Journal:  AIDS       Date:  1993-09       Impact factor: 4.177

Review 5.  HIV infection among intravenous drug users: epidemiology and risk reduction.

Authors:  D C Des Jarlais; S R Friedman
Journal:  AIDS       Date:  1987-07       Impact factor: 4.177

6.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

7.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

Authors:  Lut Van Damme; Gita Ramjee; Michel Alary; Bea Vuylsteke; Verapol Chandeying; Helen Rees; Pachara Sirivongrangson; Léonard Mukenge-Tshibaka; Virginie Ettiègne-Traoré; Charn Uaheowitchai; Salim S Abdool Karim; Benoît Mâsse; Jos Perriëns; Marie Laga
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

8.  Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa.

Authors:  Laith J Abu-Raddad; Padmaja Patnaik; James G Kublin
Journal:  Science       Date:  2006-12-08       Impact factor: 47.728

9.  Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

Authors:  S H Eshleman; M Mracna; L A Guay; M Deseyve; S Cunningham; M Mirochnick; P Musoke; T Fleming; M Glenn Fowler; L M Mofenson; F Mmiro; J B Jackson
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

10.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

View more
  72 in total

1.  Antiretroviral adherence during pregnancy and postpartum in Latin America.

Authors:  Regis Kreitchmann; D Robert Harris; Fabiana Kakehasi; Jessica E Haberer; Pedro Cahn; Marcelo Losso; Elizabete Teles; Jose H Pilotto; Cristina B Hofer; Jennifer S Read
Journal:  AIDS Patient Care STDS       Date:  2012-06-04       Impact factor: 5.078

2.  Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine.

Authors:  José das Neves; Johan Michiels; Kevin K Ariën; Guido Vanham; Mansoor Amiji; Maria Fernanda Bahia; Bruno Sarmento
Journal:  Pharm Res       Date:  2011-11-10       Impact factor: 4.200

3.  The ART of preventing HIV.

Authors: 
Journal:  Nat Med       Date:  2011-01       Impact factor: 53.440

Review 4.  Developing vaccines to combat hookworm infection and intestinal schistosomiasis.

Authors:  Peter J Hotez; Jeffrey M Bethony; David J Diemert; Mark Pearson; Alex Loukas
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

5.  Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Authors:  Elijah Paintsil; Huijie He; Christopher Peters; Brett D Lindenbach; Robert Heimer
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

6.  Recent key advances in human immunodeficiency virus medicine and implications for China.

Authors:  Kai Sun; Shuntai Zhou; Ray Y Chen; Myron S Cohen; Fujie Zhang
Journal:  AIDS Res Ther       Date:  2010-05-26       Impact factor: 2.250

7.  Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.

Authors:  Denis Nash; Yingfeng Wu; Batya Elul; David Hoos; Wafaa El Sadr
Journal:  AIDS       Date:  2011-07-31       Impact factor: 4.177

8.  RAG2-/- gamma(c)-/- mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus.

Authors:  Ursula Hofer; Stefan Baenziger; Mathias Heikenwalder; Erika Schlaepfer; Nadine Gehre; Stephan Regenass; Thomas Brunner; Roberto F Speck
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

9.  Global health inequity: scientific challenges remain but can be solved.

Authors:  Carol A Dahl; Tadataka Yamada
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

10.  A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS.

Authors:  Weiguo Hu; Qigui Yu; Ningjie Hu; Daniel Byrd; Tohti Amet; Cecilia Shikuma; Bruce Shiramizu; Jose A Halperin; Xuebin Qin
Journal:  J Immunol       Date:  2009-12-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.